Enzyme Potential Target in Cancer and Autoimmune Diseases of Lung

HDAC3 enzyme can be a potential target for cancer treatments as well as for autoimmune diseases in the airway. HDAC3 plays an key role in regulating lung macrophage development and homeostasis.

Enzyme could play a key role in cancer treatment and autoimmune diseases in the airway, according to a research study.

The research is published in Nature Communications

Age-associated B Cells: Trigger for Autoimmune Disease Identified
Autoimmune disease occurs when the immune system of the body is affected with the disease. Women are more frequently affected than men.

‘HDAC3 enzyme plays an important role in regulating lung macrophage development and homeostasis. HDAC3 is a potential target for cancer treatment and inflammatory diseases of the lung.’
Read More..

Histone deacetylases (HDACs) are enzymes that help modulate gene expression by removing acetyl groups from histone or non-histone proteins. Inhibition of HDACs is emerging as a promising approach to treat various types of malignant diseases and inflammatory disorders.

"The findings from this study show the key role HDAC3, one in the large HDAC family, plays in regulating lung macrophage development and homeostasis," said Qing-Sheng Mi, M.D., Ph.D., senior author of the study, senior scientist/professor, director of the Center for Cutaneous Biology and Immunology, Department of Dermatology, and director of Immunology Program of Henry Ford Cancer Institute.

"Four pan-HDAC inhibitors have been approved by the FDA for anti-tumor therapy. However, due to common severe side effects of these pan-HDAC inhibitors, developing drugs with high selectivity for individual HDACs has become a priority for researchers."

New Biomarker for Rare Autoimmune Disease Discovered
Newly identified biomarker could open up new avenues for studying the course of a rare autoimmune disease myasthenia gravis (MG) and developing more personalized treatments, reveals a new study.

"This study sheds light on HDAC3 as a potential therapeutic target for intervention in cancer and autoimmune diseases in the airway," said Li Zhou, M.D., co-senior author, associate scientist in the Center for Cutaneous Biology and Immunology at Henry Ford.

Lung alveolar macrophages are the innate immune cells residing in lung alveoli. They are important for the maintenance of homeostasis in the airways and are involved in the development of a variety of pulmonary diseases, including asthma and lung cancer.

New Functions for Autoimmune Disease 'Risk' Gene Discovered
Infection-fighting and inflammation-suppressing functions for a gene associated with human autoimmune disease have been discovered by University of Minnesota researchers.

"According to the findings of this study, the deletion of HDAC3 in mouse alveolar macrophages leads to significant impairment of alveolar macrophage development, maintenance, maturation and regeneration," said Yi Yao, Ph.D., the first author in the paper and a research instructor from Dr. Mi’s laboratory.

More research is needed to better understand the underlying mechanism by which individual HDACs regulate immune cell development, maintenance and function. This knowledge will help with identifying potential therapeutic treatments.

T-cell Regulator Key to Fight Organ Rejection and Autoimmunity
Transcription factor IRF4 should be the target to solve the problem of transplant rejection or to develop an autoimmunity cure.

"Our study may help bring HDAC3-inhibitor into clinical trial for lung cancer and inflammatory diseases," said Dr. Qing-Sheng Mi.

Source-Eurekalert